Biorestorative Therapies Inc (BRTX) Live Share Price, Invest From India

Biorestorative Therapies Inc Stock Performance

as on December 18, 2025 at 2:29 am IST

Day's Low
Day's High
$1.06
Day's Price Range
$1.13
$1.12
5.36%
Downside
0.89%
Upside
52 Week's Low
52 Week's High
$0.98
52-Week Price Range
$2.55
$1.12
12.13%
Downside
127.68%
Upside

Biorestorative Therapies Inc share price movements today

Previous Close: $1.08
Open: $1.06
Volume: 314.0K
Day's Low - High: $1.06 - $1.13
52 Week Low - High: $0.98 - $2.55

Biorestorative Therapies Inc Historical Returns

1 Month Return: -11.29 %
3 Month Return: -24.14 %
1 Year Return: -21.99 %
3 Year Return: -63.09 %
5 Year Return: 0 %

Biorestorative Therapies Inc Stock Fundamentals & Key Indicators

Check Biorestorative Therapies Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.8M

EPS (TTM)

-1.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-14.3M

Revenue (TTM)

383.4K

Profit Margin

0.00%

Return On Equity TTM

-207.73%

Biorestorative Therapies Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biorestorative Therapies Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Biorestorative Therapies Inc	BUY	$9.8M	NA	NA	0.00%
Insmed Incorporated	BUY	$42.3B	434.64%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$51.7B	175.37%	1261.84	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$116.6B	89.9%	32.06	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$79.1B	50.29%	17.89	32.13%

Stock Returns calculator for Biorestorative Therapies Inc Stock including INR - Dollar returns

The Biorestorative Therapies Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Biorestorative Therapies Inc investment value today

Current value as on today

₹85,741

Returns

₹14,259

(-14.26%)

Returns from Biorestorative Therapies Inc Stock

₹20,567 (-20.57%)

Dollar Returns*

₹6,308 (+6.31%)

Analyst Recommendation on Biorestorative Therapies Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Biorestorative Therapies Inc. Average target price of $13

Biorestorative Therapies Inc Share Price Target

Get share price movements and forecasts by analysts on Biorestorative Therapies Inc.

What analysts predicted

91.38%UPSIDE

Target Price

$13

Current Price

$1.12

Analyzed by

8 Analysts

Target

$13.00

Biorestorative Therapies Inc target price $13, a slight upside of 91.38% compared to current price of $1.12. According to 8 analysts rating.

Biorestorative Therapies Inc Stock’s Investor Sentiment and Interest

Search interest for Biorestorative Therapies Inc Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: November 18, 2025 to December 18, 2025

Change:7% versus previous 30 day period

Biorestorative Therapies Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	-	0	0	0	0	0	0	0
Operating Income	-3	-3	-3	-4	-2	-2	-2	-4	-3	-3
EBITDA	-5	-2	-	-4	-2	-2	-2	-4	-2	-2
Interest Expense	0	0	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	4	-2	-2	-4	-1	-1	-5	-2	-3
Income Tax Expense	0	0	-	0	0	-	0	-	-	-
Net Income	-5	4	-2	-2	-4	-1	-1	-5	-2	-3
Net Profit Margin	-8851.78%	15531.79%	-14638.44%	-6352.16%	-4521.39%	-467.22%	-3778.63%	-21359.20%	-875.79%	-25748.11%

Biorestorative Therapies Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	-	0	0	0	0	0
Operating Income	-7	-7	-8	-7	-8	-2	-26	-18	-15	-11
EBITDA	-7	-7	-8	-9	-9	-9	-26	-18	-14	-11
Interest Expense	0	0	1	3	5	1	1	0	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-7	-8	-9	-12	-14	-11	-44	-13	-10	-8
Income Tax Expense	0	0	1	-1	-	3	-14	0	0	-
Net Income	-7	-8	-9	-12	-14	-11	-44	-13	-10	-8
Net Profit Margin	-1259.87%	-23755.44%	-11660.07%	-11277.30%	-11267.61%	-14639.85%	-96311.51%	-11036.97%	-7145.20%	-2239.25%

Biorestorative Therapies Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	4	-2	-2	-4	-1	-1	-5	-2	-3
Operating Cash Flow	-1	-1	-2	-1	-1	-2	-2	-2	-2
Investing Cash Flow	0	-	-4	2	0	1	2	2	1
Financing Cash Flow	1	0	7	0	-	0	1	0	0
Change in Cash	0	-1	0	1	0	0	0	0	0

Biorestorative Therapies Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-8	-9	-12	-14	-11	-44	-13	-10	-8
Operating Cash Flow	-5	-3	-5	-6	-1	-3	-5	-6	-8
Investing Cash Flow	0	0	0	0	0	0	-13	3	0
Financing Cash Flow	5	4	4	6	5	21	21	2	7
Change in Cash	0	0	0	0	3	17	-19	0	0

Global Institutional Holdings in Biorestorative Therapies Inc

Funds	Holdings
Geode Capital Management, LLC	0.68%
Wealth Alliance, LLC	0.5%
StoneX Group Inc	0.47%
Morgan Stanley - Brokerage Accounts	0.44%
Vanguard Group Inc	0.37%

See all

Insights on Biorestorative Therapies Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 183.5% return, outperforming this stock by 205.5%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 939.1% return, outperforming this stock by 1002.2%
NEGATIVE IMPACT
Price Dip
In the last 1 month, BRTX stock has moved down by -11.3%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 303.3K → 11.8K (in $), with an average decrease of 96.1% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -2.65M → -3.03M (in $), with an average decrease of 14.4% per quarter

About Biorestorative Therapies Inc

biorestorative therapies, inc. (www.biorestorative.com) develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. our two core programs, as described below, relate to the treatment of disc/spine disease and metabolic disorders: • disc/spine program (brtxdisc™): our lead cell therapy candidate, brtx-100, is a product formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow. we intend that the product will be used for the non-surgical treatment of protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. the brtx-100 production process involves collecting a patient’s bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. in an outpatient procedure, brtx-100 is to be injected by a physician into the patient’s damaged disc. the treatment is intended for patients whose pain has not been alleviated by non-invas

Organisation	Biorestorative Therapies Inc
Headquarters	40 Marcus Drive, Melville, NY, United States, 11747
Industry	Biotechnology
CEO	Mr. Lance Alstodt
E-voting on shares	Click here to vote

Key Management of Biorestorative Therapies Inc

Name	Title
Mr. Robert Eugene Kristal	Chief Financial Officer
Mr. Francisco J. Silva	VP of Research & Development, Secretary and Director
Stephen Kilmer	Investor Relations Officer
Ms. Crystal Romano	Head of Global Commercial Operations
Mr. Lance Alstodt	Chairman of the Board, President & CEO

FAQs

What is Biorestorative Therapies Inc share price today?

Biorestorative Therapies Inc share price today is $1.12 as on December 18, 2025 at 2:29 am IST at the close of the market. Biorestorative Therapies Inc share today touched a day high of $1.13 and a low of $1.06.

What is the 52 week high and 52 week low for Biorestorative Therapies Inc share?

Biorestorative Therapies Inc share touched a 52 week high of $2.55 on January 29, 2025 and a 52 week low of $0.98 on December 1, 2025. Biorestorative Therapies Inc stock price today i.e. December 18, 2025 at 2:29 am IST is closed at $1.12,which is 56.08% down from its 52 week high and 13.81% up from its 52 week low.

What is Biorestorative Therapies Inc's market capitalisation today?

Biorestorative Therapies Inc market capitalisation is $0.00T as on December 18, 2025 at 2:29 am IST.

How to invest in Biorestorative Therapies Inc Stock (BRTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Biorestorative Therapies Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biorestorative Therapies Inc Shares that will get you 1.3393 shares as per Biorestorative Therapies Inc share price of $1.12 per share as on December 18, 2025 at 2:29 am IST.

What is the minimum amount required to buy Biorestorative Therapies Inc Stock (BRTX) from India?

Indian investors can start investing in Biorestorative Therapies Inc (BRTX) shares with as little as ₹90.25 or $1 (as of December 18, 2025 at 7:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹902.50 in Biorestorative Therapies Inc stock (as per the Rupee-Dollar exchange rate as on December 18, 2025 at 7:41 pm IST). Based on Biorestorative Therapies Inc share’s latest price of $1.12 as on December 18, 2025 at 2:29 am IST, you will get 8.9286 shares of Biorestorative Therapies Inc. Learn more about fractional shares .